News from NYU Langone Health

NYU Langone Appoints New CEO. (Crain's New York Business)

Paywalled* Crain’s New York Business (3/31) Alec Kimmelman, MD, PhD, the Anita Steckler and Joseph Steckler Chair, and professor, Department of Radiation Oncology, Perlmutter Cancer Center, has been appointed as the next CEO of NYU Langone Health and dean of the NYU Grossman School of Medicine, effective September 1. Kimmelman, who joined NYU Langone Health in 2016 and currently serves as chair of radiation oncology and director of NYU Langone Health’s Perlmutter Cancer Center, said, “I am humbled and excited to be the next CEO and dean of NYU Langone Health and appreciate the confidence the board of trustees and the search committee have placed in me.” The story also appeared in Modern Healthcare (3/31)*.

The New York Post (3/31) Robert I. Grossman, MD, dean and CEO, ”commended his successor’s accomplishments, particularly his groundbreaking research in molecular oncology,” saying, “Throughout his career at NYU Langone Health, most recently leading Perlmutter Cancer Center, Dr. Kimmelman has further established our integrated academic health system as a leader in research and treatment.” Incoming board chair Fiona B. Druckenmiller said, “Ken and Dr. Grossman shared a bold vision and an amazing partnership that made NYU Langone Health what it is today. I am excited to cultivate a similar working relationship with Dr. Kimmelman as we forge ahead together to bring the highest quality care to our patients and communities.”

Becker’s Hospital Review (3/31) Kenneth Langone, chair of the NYU Langone board of trustees and co-chair of the search committee, said, “We are excited to name Dr. Kimmelman to this position, given his extraordinary talent, leadership experience and strong character.” Dr. Robert Grossman will transition to executive vice president to the board, and Fiona B. Druckenmiller will take over as board chair as Kenneth Langone steps down from the role but remains a board member. 

Also covering the story is CityBiz (3/31).

NYU Langone Appoints Next CEO, Med School Dean. (Fierce Healthcare)

Fierce Healthcare (4/1) NYU Langone Health has appointed Alec Kimmelman, MD, PhD, the Anita Steckler and Joseph Steckler Chair, and professor, Department of Radiation Oncology, Perlmutter Cancer Center, as its next CEO and dean of the NYU Grossman School of Medicine, effective September 1, following the retirement of Robert I. Grossman, MD, dean and CEO, who led the system for 18 years and will now serve as executive vice president to the Board of Trustees; Dr. Kimmelman, who has been with NYU Langone Health since 2016 and has served as director of NYU Langone Health’s Laura and Isaac Perlmutter Cancer Center since 2023, has an extensive background in medical research with over 100 published articles on oncology, contributing to pancreatic cancer clinical trials.

Also reporting is DOT Med News (4/1).

Wrinkles Begone: Dermatologists Reveal The Best Lasers For Lines, Sagging, Stretch Marks And Spots. (New York Post)

The New York Post (4/1) NYU Langone Health dermatologic surgeons Lisa O. Akintilo, MD, assistant professor, the Ronald O. Perelman Department of Dermatology, Maressa C. Criscito, MD, assistant professor, the Ronald O. Perelman Department of Dermatology, discussed the benefits of laser treatments for various skin concerns, such as fine lines, wrinkles, sagging skin, scars, and uneven skin tone, with Dr. Akintilo recommending non-ablative fractional lasers for collagen stimulation and pigmentation issues, and Dr. Criscito advocating for Fraxel and radiofrequency microneedling for scars and Sofwave for skin tightening, while both experts emphasized the need for multiple sessions to achieve desired results.

Therapy Dog Helps Patients Recover At NYU Langone Health. (NBC)

NBC (4/1) NBC’s John Chandler reported on the heartwarming reunion between five-year-old Liam from New York and Dot, a therapy dog who assisted him in his recovery from major spinal cord surgery at NYU Langone Health, where Liam has been receiving care since he was six months old; Dot, a three-year-old lab trained by America’s VetDogs, has been instrumental in helping children like Liam through physical therapy by providing motivation and comfort, demonstrating commands, and engaging in activities, with the hospital noting that Dot has connected with 655 patients since her arrival.

Trump Said Auto Emissions Don’t Affect the Environment. That’s Not True. (New York Times)

The New York Times (4/1) President Trump announced on Monday his intention to ease restrictions on vehicle emissions, asserting it would not impact the environment, although transportation is the largest source of greenhouse gases in the US; George D. Thurston, PhD, professor, Departments of Medicine, Division of Environmental Medicine, and Department of Population Health highlighted the health risks of vehicle emissions, noting their role in diseases like lung cancer and asthma.

‘Hidden Hypertension’ Buried In EHRs: What To Know. (Becker's Hospital Review)

Becker’s Hospital Review (4/1) Researchers from NYU Grossman School of Medicine and Harvard Medical School developed an AI algorithm that identified undiagnosed hypertension in 648 patients by analyzing electronic health records at Mass General Brigham, with 15.6% of notified patients receiving diagnoses compared to 4% in the control group; the study authors said, “This work highlights the potential benefit of leveraging preexisting, but potentially underutilized, cardiovascular data to improve health care delivery.”

Is Creatine The Midlife Wonder Supplement You’re Missing? (Oprah Daily)

Oprah Daily (3/25) Creatine, a compound naturally produced in the body and found in animal-based foods, is gaining popularity among middle-aged women for its potential benefits in muscle and cognitive health, with Heather A. Milton, MS, RCEP, CSCS, exercise physiologist supervisor, explaining that “creatine phosphate stored in muscles is responsible for supplying energy for quick anaerobic bouts of muscle contraction.”

Don’t Overlook Processed Meat As CRC Risk Factor. (Medscape)

Medscape (4/2)* Peter S. Liang, MD, MPH, assistant professor, Department of Medicine, Division of Gastroenterology and Hepatology, and Department of Population Health, said, “While I routinely counsel my patients about lifestyle and dietary risk factors for CRC, including processed meat, I’m not sure how often this is specifically mentioned by physicians in practice,” highlighting the importance of educating patients on the risks of processed meats.

How NYC Seniors Can Stay Mentally Sharp After 60 – Science-Backed Strategies. (Healthworks Collective)

Healthworks Collective (4/1) A study from NYU Langone Health revealed that the decline of brain chemicals essential for energy production and function, such as acetyl-L-carnitine and free carnitine, is linked to cognitive impairment, including Alzheimer’s disease; study lead investigator Betty Bigio, PhD, research assistant professor, Department of Psychiatry, said these chemicals “could serve as biomarkers for identifying those with Alzheimer’s disease and potentially those at greater risk for early brain aging.”

Use Of Melatonin May Yield Longer Sleep Duration After THA. (Healio)

Healio (4/1) At the American Academy of Orthopaedic Surgeons Annual Meeting, research from NYU Langone Health revealed that patients prescribed melatonin after total hip arthroplasty (THA) reported increased sleep duration postoperatively, with Joshua C. Rozell, MD, associate professor, Department of Orthopedic Surgery, chief, Orthopedic Surgery, NYU Langone Hospital–Brooklyn, saying, “Melatonin may be of benefit in the first few weeks after surgery,” though the benefits diminish after a few days, and Farouk J. Khury, MD, clinical research fellow, presented data showing a statistically significant improvement in sleep disturbance scores on postoperative day 14 for those in the melatonin group.

New Chief Nurse Executive At The Brooklyn Hospital Center. (Brooklyn (NY) Daily Eagle)

The Brooklyn (NY) Daily Eagle (4/1) The Brooklyn Hospital Center announced Kimberly F. Volpe as its new chief nurse executive, bringing over 20 years of experience, previously serving as Senior Director of Nursing at Montefiore Medical Center-Wakefield; Volpe has held leadership roles at NYU Langone Orthopedic Hospital and is an adjunct professor at New York University.

Gene Therapy: Medical Progress Has A Price, Says Ethicist. (Medscape)

Paywalled* Medscape (4/1)* Art Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics, highlighted the risks and potential of gene therapy, emphasizing that while gene therapy offers hope, it carries significant risks, including unintended genetic effects.